Approval for minor design changes to the 6f/7f mynx vascular closure device.  The device, as modified, will be marketed under the trade name m5 mynx vascular closure device and is indicated for use to seal femoral arterial access sites while reducing times to hemostasis and ambulation in patients who have undergone diagnostic or interventional endovascular procedures utilizing a 5f procedural sheath.